NeoMatrix Therapeutics Enters Clinical Stage as IND for NMT-cP12 Goes Into Effect
- Potential First-in-Class Treatment for Serious Burn Injuries Targets PDGF -
top of page
News
NeoMatrix Therapeutics
25 Health Sciences Drive, Suite 124
Stony Brook, NY 11790
© 2020 NeoMatrix Therapeutics, Inc. All rights reserved.
bottom of page